A systematic review of the diagnostic accuracy of prostate specific antigen

BMC Urology

Volumn 9, Issue 1, 2009, Pages

  Harvey, Philip ^a   Basuita, Amman ^a   Endersby, Deborah ^a   Curtis, Ben ^a   Iacovidou, Aphrodite ^a   Walker, Mary ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; EMBASE; EUROPE; HISTOLOGY; HUMAN; MEDLINE; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; BLOOD; MALE; PROSTATE TUMOR; REPRODUCIBILITY; REVIEW;

HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 70349667018     PISSN: 14712490     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-9-14     Document Type: Article

References (19)

1. Office of National Statistics: Registrations of cancers diagnosed in 2005 England. http://www.statistics.gov.uk/downloads/theme-health/MB1-36/MB1-No36- 2005.pdf
2. Office of National Statistics: Review of the general register on deaths by cause, sex and age in England and Wales. http://www.statistics.gov.uk/ downloads/theme-health/Dh2-32/DH2-No32-2005.pdf
3. Cancer incidence and mortality in Europe, 2004. P Boyle J Ferlay, Annals of Oncology 2005 16 481 488 10.1093/annonc/mdi098 15718248
4. Estimates of the cancer incidence and mortality in Europe in 2006. J Ferlay P Autier M Boniol M Heanue M Colombet P Boyle, Annals of Oncology 2007 18 581 592 10.1093/annonc/mdl498 17287242 (Pubitemid 46359643)
5. The PSA test and prostate cancer: information for primary care. E Watson L Jenkins C Bukach J Austoker, NHS cancer screening programme, Sheffield 2002
6. National Institute of Clinical Excellence: Prostate cancer diagnosis and treatment. http://www.nice.org.uk/nicemedia/pdf/CG58FullGuideline.pdf
7. eMedicine: Prostate Specific Antigen. SA Brosman, http://emedicine. medscape.com/article/457394-overview
8. National institute of clinical excellence: Referral guidelines for suspected cancer in adults and children, part two. http://www.nice.org.uk/ nicemedia/pdf/CG27-FullGuidance-Part2.pdf
9. European association of Urology: Guidelines on prostate cancer. http://www.uroweb.org/fileadmin/count.php?f=fileadmin%2Ftx- eauguidelines%2F2009%2FFull%2FProstate-Cancer.pdf
10. WHO expert committee on biological standardisation, technical report series. World Health Organisation, Geneva 1999 10.1373/clinchem.2006.069039
11. Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96/670 reference preparation. SA Kort F Martans H Vanpoucke HL van Duijnhoven MA Blankenstein, Clinical chemistry 2006 52 1568 1574 10.1373/clinchem.2006.069039 16762996
12. Better reporting of studies of diagnostic accuracy. M Pai S Sharma, Indian Journal of Medical Microbiology 2005 23 4 210 213 10.1186/1471-2288-3-25 16327114
13. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. P Whiting AW Rutjes JB Reitsma PM Bossuyt J Kleijnen, BMC Med Res Methodol 2003 3 25 10.1136/bmj.323.7305.157 14606960
14. Systematic reviews of evaluations of diagnostic and screening tests. J Deeks, BMJ 2001 323 157 162 11463691 10.1136/bmj.323.7305.157
15. Chapter 7 Searching for Studies. HCW de Vet A Eisinga II Riphagen B Aertgeerts D Pewsner, Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 [updated September 2008] The Cochrane Collaboration 2008
16. Interchangeability and diagnostic accuracy of two assays for total and free prostate-specific antigen: two not always related items. R Dittadir R Franceschini A Fortunato M Zancan M Barichello A Tasca D Giavarina L Peloso G Soffiati M Gion, International journal of biological markers 2007 22 154 158 10.1002/cncr.21267 17549671
17. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL. C Stephan G Stroebel M Heinau A Lenz A Roemer M Lein D Schnorr SA Loening K Jung, Cancer 2005 104 993 1003 10.1016/S0302-2838(02)00278-6 16007682
18. Different PSA assays lead to detection of prostate cancers with identical histological features. G Yurdakul CH Bangma BG Blijenberg BD van Zelst MF Wildhagen TH van der Kwast FH Schroder, European Urology 2002 42 154 158 10.1016/S0302-2838(02)00278-6 12160586
19. Free to total PSA ration is not a reliable predictor of prostate biopsy outcome. S Ciatto T Rubeca M Confortini G Pontenani C Lombardi P Zendron S Di Lollo E Crocetti, Tumori 2004 90 324 327 15315313